Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

Surrozen, Inc./DE (SRZN) Stock Forecast 2025 - AI Price Prediction & Analysis

Surrozen, Inc./DE (SRZN) AI Stock Price Forecast & Investment Analysis

Surrozen, Inc./DE Stock Price Chart and Technical Analysis

Loading Surrozen, Inc./DE interactive price chart and technical analysis...

Surrozen, Inc./DE (SRZN) - Comprehensive Stock Analysis & Investment Research

Deep dive into Surrozen, Inc./DE's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Surrozen, Inc./DE, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Surrozen, Inc./DE: Surrozen, Inc./DE operates in the Life Sciences sector, making it an emerging small-cap investment.

Surrozen, Inc./DE (Stock Symbol: SRZN) is a leading company in the Life Sciences sector , specifically operating within the Biological Products, (No Diagnostic Substances) industry.

The organization employs approximately 97 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Surrozen, Inc./DE's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Surrozen, Inc./DE:

Market Capitalization: $118 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -48.3% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Surrozen, Inc./DE stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Surrozen, Inc./DE: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Surrozen, Inc./DE stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Surrozen, Inc./DE's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Surrozen, Inc./DE: Market positioning analysis based on available financial and operational metrics.

Surrozen, Inc./DE strategically competes in the highly dynamic Biological Products, (No Diagnostic Substances) marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

Surrozen, Inc./DE (SRZN) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Surrozen, Inc./DE stock analysis.

Loading Surrozen, Inc./DE comprehensive fundamental analysis and insider trading data...

Deep dive into Surrozen, Inc./DE's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Surrozen, Inc./DE stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Surrozen, Inc./DE: With a P/E ratio of -0.49, the market sees the stock as potentially undervalued.

P/E Ratio -0.49x
P/B Ratio 2.50x
Market Cap $118M
EPS $-2.48
Book Value/Share $5.50
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Surrozen, Inc./DE converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Surrozen, Inc./DE: An ROE of -48.3% indicates room for improvement in shareholder value creation.

ROE -48.3%
ROA -42.1%
ROIC -45.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Surrozen, Inc./DE's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Surrozen, Inc./DE: A current ratio of 11.79 indicates strong liquidity.

Current Ratio 11.79x
Quick Ratio 11.40x
D/E Ratio 0.05x
Financial Leverage 1.14x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Surrozen, Inc./DE's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Surrozen, Inc./DE: Free cash flow of $-58M indicates cash challenges that need attention.

Operating Cash Flow $-57M
Free Cash Flow $-58M
Capital Spending $-1M
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Surrozen, Inc./DE uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Surrozen, Inc./DE:

Understanding Financial Statement Data

What these metrics mean: Key figures from Surrozen, Inc./DE's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Surrozen, Inc./DE:

Income Statement ($ Millions)
Operating Income $-2M
Net Income $-35M
R&D Expense $22M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 81%
Cash & Short-term Investments 79%
Total Liabilities 13%
Dividend & Shareholder Information
Shares Outstanding 9M
Growth Metrics (YoY)
EPS Growth -280.7%

Latest Surrozen, Inc./DE Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Surrozen, Inc./DE (SRZN) stock price and investment outlook.

📰 We are currently updating our news feed for Surrozen, Inc./DE. Check back soon for the latest market analysis and company updates.

Surrozen, Inc./DE Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Surrozen, Inc./DE against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ABOS Unlock Forecast - 30 Days FREE Trial $130M -1.9x 1.1x
ABP Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
ACOG Unlock Forecast - 30 Days FREE Trial $112M x 3.5x
ADAP Unlock Forecast - 30 Days FREE Trial $294M -13.2x -11.8x
ADMA Unlock Forecast - 30 Days FREE Trial $3476M 16.6x 8.7x
ADPT Unlock Forecast - 30 Days FREE Trial $2551M -4.6x 14.2x
AGEN Unlock Forecast - 30 Days FREE Trial $119M -0.5x -0.5x
AIM Unlock Forecast - 30 Days FREE Trial $2M -0.5x -183.3x
AIMI Unlock Forecast - 30 Days FREE Trial $2M x x
ALEC Unlock Forecast - 30 Days FREE Trial $306M -1.2x 4.3x
ALGS Unlock Forecast - 30 Days FREE Trial $89M -19.2x 0.9x
ALLO Unlock Forecast - 30 Days FREE Trial $271M -1.4x 0.8x
AMGN Unlock Forecast - 30 Days FREE Trial $159235M 24.1x 21.4x
APGE Unlock Forecast - 30 Days FREE Trial $3178M -20.5x 4.3x
APTOF Unlock Forecast - 30 Days FREE Trial $3M x x
ARMP Unlock Forecast - 30 Days FREE Trial $115M -1.0x -1.6x
ARTV Unlock Forecast - 30 Days FREE Trial $68M x 0.5x
ATHA Unlock Forecast - 30 Days FREE Trial $150M -0.2x 4.7x
ATRA Unlock Forecast - 30 Days FREE Trial $166M 28.6x -1.1x
AURA Unlock Forecast - 30 Days FREE Trial $367M -4.9x 2.1x
AUTL Unlock Forecast - 30 Days FREE Trial $442M x 1.3x
AVXL Unlock Forecast - 30 Days FREE Trial $792M -17.3x 8.7x
BCLI Unlock Forecast - 30 Days FREE Trial $7M -4.9x -0.9x
BDTX Unlock Forecast - 30 Days FREE Trial $235M 16.3x 1.8x
BEAM Unlock Forecast - 30 Days FREE Trial $2617M -12.6x 2.5x
BIIB Unlock Forecast - 30 Days FREE Trial $20870M 13.6x 1.4x
CABA Unlock Forecast - 30 Days FREE Trial $212M -1.6x 1.2x
CCCC Unlock Forecast - 30 Days FREE Trial $160M -2.6x 0.9x
CELZ Unlock Forecast - 30 Days FREE Trial $9M -3.4x 1.3x
CERO Unlock Forecast - 30 Days FREE Trial $1M x -196.2x
CGEN Unlock Forecast - 30 Days FREE Trial $173M x 3.4x
CGON Unlock Forecast - 30 Days FREE Trial $3141M x 4.7x
CGTX Unlock Forecast - 30 Days FREE Trial $119M -0.5x 16.9x
CHRS Unlock Forecast - 30 Days FREE Trial $194M 1.1x 1.6x
CLDI Unlock Forecast - 30 Days FREE Trial $5M -0.9x 3.0x
CMPX Unlock Forecast - 30 Days FREE Trial $586M -4.8x 6.3x
CRBU Unlock Forecast - 30 Days FREE Trial $232M -1.5x 1.4x
CRDF Unlock Forecast - 30 Days FREE Trial $147M -4.0x 2.5x
CRIS Unlock Forecast - 30 Days FREE Trial $16M -0.3x -2.9x
CRSP Unlock Forecast - 30 Days FREE Trial $6048M -12.1x 3.5x
CVM Unlock Forecast - 30 Days FREE Trial $51M -0.9x 7.3x
DTIL Unlock Forecast - 30 Days FREE Trial $65M -2.2x 1.9x
ELUT Unlock Forecast - 30 Days FREE Trial $40M -1.4x -0.1x
ENGN Unlock Forecast - 30 Days FREE Trial $429M 3.7x 2.1x
ENTX Unlock Forecast - 30 Days FREE Trial $120M 8.5x 7.0x
ESLA Unlock Forecast - 30 Days FREE Trial $48M -3.1x -16.9x
EXEL Unlock Forecast - 30 Days FREE Trial $10592M 17.6x 5.2x
EXOZ Unlock Forecast - 30 Days FREE Trial $109M x 15.0x
FATE Unlock Forecast - 30 Days FREE Trial $194M -1.3x 0.7x
FDMT Unlock Forecast - 30 Days FREE Trial $497M -3.0x 1.2x
FENC Unlock Forecast - 30 Days FREE Trial $238M 1758.3x -39.7x
FNCH Unlock Forecast - 30 Days FREE Trial $20M -0.1x 1.4x
FTII Unlock Forecast - 30 Days FREE Trial $-26M x -0.7x
FTIIU Unlock Forecast - 30 Days FREE Trial $-26M x -0.8x
GILD Unlock Forecast - 30 Days FREE Trial $146370M 23.2x 7.4x
GLUE Unlock Forecast - 30 Days FREE Trial $832M 34.4x 3.1x
GNTA Unlock Forecast - 30 Days FREE Trial $59M x 4.8x
GPLB Unlock Forecast - 30 Days FREE Trial $M x x
HALO Unlock Forecast - 30 Days FREE Trial $7866M 14.1x 23.6x
HLVX Unlock Forecast - 30 Days FREE Trial $105M -0.6x 0.7x
HUMA Unlock Forecast - 30 Days FREE Trial $244M -3.3x 60.2x
IKT Unlock Forecast - 30 Days FREE Trial $145M -1.0x 1.8x
IMCR Unlock Forecast - 30 Days FREE Trial $1686M x 4.3x
IMVT Unlock Forecast - 30 Days FREE Trial $2957M -14.5x 4.9x
INBX Unlock Forecast - 30 Days FREE Trial $502M -6.8x 7.3x
INKT Unlock Forecast - 30 Days FREE Trial $56M -1.5x -1.4x
INMB Unlock Forecast - 30 Days FREE Trial $49M -2.5x 1.7x
INTS Unlock Forecast - 30 Days FREE Trial $8M -2.2x 3.7x
IOVA Unlock Forecast - 30 Days FREE Trial $737M -4.5x 1.1x
IPSC Unlock Forecast - 30 Days FREE Trial $49M -0.7x 0.2x
IVVD Unlock Forecast - 30 Days FREE Trial $211M -0.4x 4.9x
JSPR Unlock Forecast - 30 Days FREE Trial $39M -3.2x 1.7x
KLRS Unlock Forecast - 30 Days FREE Trial $83M x 1.6x
KLTO Unlock Forecast - 30 Days FREE Trial $31M x 2.9x
KOD Unlock Forecast - 30 Days FREE Trial $627M -2.5x 8.9x
KRYS Unlock Forecast - 30 Days FREE Trial $5448M 37.1x 5.2x
KYMR Unlock Forecast - 30 Days FREE Trial $4266M -17.8x 4.4x
KYTX Unlock Forecast - 30 Days FREE Trial $287M x 1.6x
LADX Unlock Forecast - 30 Days FREE Trial $M x x
LCTX Unlock Forecast - 30 Days FREE Trial $369M -4.7x 7.6x
LENZ Unlock Forecast - 30 Days FREE Trial $1154M -6.7x 5.6x
LIMN Unlock Forecast - 30 Days FREE Trial $0M x x
LXEO Unlock Forecast - 30 Days FREE Trial $445M -0.4x 3.2x
MAZE Unlock Forecast - 30 Days FREE Trial $1216M x 4.6x
MGX Unlock Forecast - 30 Days FREE Trial $107M x 0.6x
MRNA Unlock Forecast - 30 Days FREE Trial $10557M -3.2x 1.1x
NBIX Unlock Forecast - 30 Days FREE Trial $13614M 39.1x 5.1x
NMRA Unlock Forecast - 30 Days FREE Trial $305M -3.9x 1.7x
NVAX Unlock Forecast - 30 Days FREE Trial $1312M 3.1x 34.9x
PASG Unlock Forecast - 30 Days FREE Trial $27M -0.6x 0.7x
PCVX Unlock Forecast - 30 Days FREE Trial $5659M -20.4x 1.8x
PHGE Unlock Forecast - 30 Days FREE Trial $16M 1.5x 0.8x
PLUR Unlock Forecast - 30 Days FREE Trial $4M -1.4x -9.1x
PLX Unlock Forecast - 30 Days FREE Trial $183M 29.2x 3.7x
PRME Unlock Forecast - 30 Days FREE Trial $764M -1.5x 12.6x
PROK Unlock Forecast - 30 Days FREE Trial $184M x 0.0x
QGEN Unlock Forecast - 30 Days FREE Trial $10816M x 3.0x
QNCX Unlock Forecast - 30 Days FREE Trial $100M -1.7x 8.5x
RGNX Unlock Forecast - 30 Days FREE Trial $562M -1.8x 2.6x
RLAY Unlock Forecast - 30 Days FREE Trial $1134M -2.0x 1.7x
RXRX Unlock Forecast - 30 Days FREE Trial $2748M -4.7x 3.0x
SANA Unlock Forecast - 30 Days FREE Trial $1028M -2.1x 8.4x
SCNI Unlock Forecast - 30 Days FREE Trial $8720M -287.8x 1109.7x
SGMO Unlock Forecast - 30 Days FREE Trial $160M -1.6x 8.2x
SLXN Unlock Forecast - 30 Days FREE Trial $2M x 18.7x
SRZN Unlock Forecast - 30 Days FREE Trial $118M -0.5x 2.5x
STRO Unlock Forecast - 30 Days FREE Trial $68M -1.0x -2.5x
TARA Unlock Forecast - 30 Days FREE Trial $217M -2.1x 1.5x
TARS Unlock Forecast - 30 Days FREE Trial $3201M -12.4x 9.6x
TCBPY Unlock Forecast - 30 Days FREE Trial $15M x 13.6x
TCRX Unlock Forecast - 30 Days FREE Trial $287M -4.6x 1.6x
TECX Unlock Forecast - 30 Days FREE Trial $300M -8.9x 1.1x
TNYA Unlock Forecast - 30 Days FREE Trial $287M -2.5x 2.9x
TRML Unlock Forecast - 30 Days FREE Trial $1231M -3.5x 4.8x
TSHA Unlock Forecast - 30 Days FREE Trial $1385M -3.0x 5.6x
TVGN Unlock Forecast - 30 Days FREE Trial $138M x -29.3x
TWST Unlock Forecast - 30 Days FREE Trial $1856M -12.6x 3.9x
VACH Unlock Forecast - 30 Days FREE Trial $-1443M x 0.0x
VACHU Unlock Forecast - 30 Days FREE Trial $-1454M x 0.0x
VCEL Unlock Forecast - 30 Days FREE Trial $1753M 246.6x 5.7x
VIR Unlock Forecast - 30 Days FREE Trial $806M -2.0x 0.9x
VOR Unlock Forecast - 30 Days FREE Trial $3924M -0.6x 3.9x
VXRT Unlock Forecast - 30 Days FREE Trial $80M -0.9x 2.4x
VYGR Unlock Forecast - 30 Days FREE Trial $293M 570.6x 1.2x
ZIVO Unlock Forecast - 30 Days FREE Trial $50M -31.3x -2.0x

Frequently Asked Questions - Surrozen, Inc./DE Stock Forecast

How accurate are Surrozen, Inc./DE stock predictions?

Our AI model demonstrates 26% historical accuracy for SRZN predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Surrozen, Inc./DE stock price forecasts?

Our analysis considers Surrozen, Inc./DE's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Surrozen, Inc./DE a good investment in 2025?

Based on our AI analysis, Surrozen, Inc./DE shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Surrozen, Inc./DE forecasts updated?

Surrozen, Inc./DE stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Surrozen, Inc./DE Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Surrozen, Inc./DE stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...